文献速递心律失常

年轻Brugada综合征患者心律失常事件的特征与管理

Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究纳入57例≤20岁Brugada综合征且发生心律失常事件的患者,分为儿童组(≤12岁,n=26)和青少年组(13-20岁,n=31)。首次事件中位年龄14岁,84%表现为心脏骤停复苏,28%为发热相关事件。随访期间儿童组68%、青少年组64%出现复发事件,中位时间分别为9.9和27.0个月。

要点

  • 年轻BrS患者首次心律失常事件多为心脏骤停,发热是重要诱因。
  • 复发率高,儿童组复发中位时间短于青少年组。
  • 约三分之一复发事件发生在使用奎尼丁治疗期间。

核心结论

  • 年轻BrS合并心律失常事件患者具有高度致心律失常性,当前首次事件后的管理策略复发率高,应考虑除植入除颤器外的替代疗法。

研究设计与样本

  • 多中心回顾性研究,纳入57例年龄≤20岁的BrS且发生心律失常事件的患者,分为儿童组(≤12岁,n=26)和青少年组(13-20岁,n=31)。

主要发现

  • 首次心律失常事件中位年龄14岁,男性占74%,白人占70%,先证者占79%,84%表现为心脏骤停复苏。
  • 28%的患者发生发热相关心律失常事件。
  • 儿童组女性、白人、发热相关事件及自发1型心电图比例高于青少年组。
  • 随访期间儿童组68%、青少年组64%出现复发事件,中位时间分别为9.9和27.0个月。
  • 约三分之一复发事件发生在奎尼丁治疗期间,儿童组中60%复发事件为发热相关。

关键数值与推荐

  • 家族性心脏性猝死史占26%,既往晕厥占49%,自发1型Brugada心电图占65%,电生理检查诱发室颤占28%,SCN5A突变占58%。
  • 儿童组复发心律失常事件的危险因素包括窦房结功能障碍、房性心律失常、室内传导延迟或I导联大S波;青少年组危险因素为SCN5A突变。

临床怎么用

  • 对年轻BrS患者应重视发热相关心律失常事件的预防与管理。
  • 首次心律失常事件后需密切监测复发,尤其儿童组复发时间更短。
  • 奎尼丁治疗期间仍可能复发,需考虑替代或联合治疗策略。

局限性

  • 样本量较小(57例),可能影响统计效能。
  • 回顾性设计可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Information on young patients with Brugada syndrome (BrS) and arrhythmic events (AEs) is limited. OBJECTIVES: The purpose of this study was to describe their characteristics and management as well as risk factors for AE recurrence. METHODS: A total of 57 patients (age ≤20 years), all with BrS and AEs, were divided into pediatric (age ≤12 years; n = 26) and adolescents (age 13 to 20 years; n = 31). RESULTS: Patients' median age at time of first AE was 14 years, with a majority of males (74%), Caucasians (70%), and probands (79%) who presented as aborted cardiac arrest (84%). A significant proportion of patients (28%) exhibited fever-related AE. Family history of sudden cardiac death (SCD), prior syncope, spontaneous type 1 Brugada electrocardiogram (ECG), inducible ventricular fibrillation at electrophysiological study, and SCN5A mutations were present in 26%, 49%, 65%, 28%, and 58% of patients, respectively. The pediatric group differed from the adolescents, with a greater proportion of females, Caucasians, fever-related AEs, and spontaneous type-1 ECG. During follow-up, 68% of pediatric and 64% of adolescents had recurrent AE, with median time of 9.9 and 27.0 months, respectively. Approximately one-third of recurrent AEs occurred on quinidine therapy, and among the pediatric group, 60% of recurrent AEs were fever-related. Risk factors for recurrent AE included sinus node dysfunction, atrial arrhythmias, intraventricular conduction delay, or large S-wave on ECG lead I in the pediatric group and the presence of SCN5A mutation among adolescents. CONCLUSIONS: Young BrS patients with AE represent a very arrhythmogenic group. Current management after first arrhythmia episode is associated with high recurrence rate. Alternative therapies, besides defibrillator implantation, should be considered.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Michowitz Y, Milman A, Andorin A, et al. Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome. J Am Coll Cardiol. 2019. PMID: 30975291. doi:10.1016/j.jacc.2019.01.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。